0
     

Report Added
Report already added
Global Peptide Therapeutics Market Report and Forecast 2022-2027

Global Peptide Therapeutics Market Report and Forecast 2022-2027

Global Peptide Therapeutics Market Report and Forecast 2022-2027

Market Outlook
According to the report by Expert Market Research (EMR), the global peptide therapeutics market size attained a value of around USD 33.58 billion in 2021. Aided by the surging cases of chronic diseases and the rising prevalence of cancer, the market is projected to further grow at a CAGR of 7.6% between 2022 and 2027 to reach a value of USD 52.26 billion by 2027.
Peptide therapeutics are described as peptide-based therapeutics employed to treat several diseases. Therapeutic peptides are referred to as naturally arising short amino acid monomer chains in the human body, shorter than 100 amino acids. They further act by binding to certain cell surface receptors, where they activate intracellular pathways and further serve as a promising basis for targeting a range of diseases. They generally act as hormones, growth factors, neurotransmitters, ion channel ligands, or anti-infective agents. They are frequently well tolerated by the body and have the potential for decreased off-target side effects. The factors like low production costs and sale prices, oral administration, and good membrane penetration ability are boosting the peptide therapeutics market demand across the globe. Moreover, the rising frequency of cancer across the globe, as along with the surging prescription of peptide therapeutics for the treatment of cancer, are aiding the market growth opportunities over the coming years.
The increasing investments in research and development activities of novel drugs coupled with technological advancements in peptide therapeutics are expected to aid the peptide therapeutics market growth across the globe. The utilisation of peptides as therapeutics has grown over time and continues to develop with changes in drug development and treatment paradigms.
Also, a significant rise in the incidences of metabolic diseases like diabetes among the growing geriatric population is driving the market growth. The hectic and busy schedule and the unhealthy lifestyles is influencing the use of peptide drugs for various treatments, this is expected to propel the peptide therapeutics market growth. The growing cases of chronic diseases like cancer and tuberculosis coupled with advancements in the field of medical science and rising healthcare spending are anticipated to fuel the global market growth.
Geographically, the North America region is anticipated to register substantial growth in the peptide therapeutics market share during the forecast period on account of the surging biotechnology industry, the surging requirement for diagnostics in cancer and other diseases, and an upsurge regarding the awareness levels linked to the products of peptide therapeutic. The well-established pharmaceutical and biopharmaceutical industry in the region is further aiding the peptide therapeutics market development in North America. Furthermore, the United States is expected to hold a significant share in the peptide therapeutics market on account of the surging number of research programs in the medical industry along with the growing prevalence of diseases in the country.

Market Segmentation
The market can be divided on the basis of marketing types, applications, routes of administration, and regions.
Market Breakup by Marketing Type
•Generic
•Branded

Market Segmentation by Application
•Gastrointestinal Disorders
•Neurological Disorders
•Metabolic Disorders
•Cancer
•Cardiovascular
•Others

Market Segmentation by Route of Administration
•Parenteral
•Oral
•Others
Market Breakup by Region
•North America
•Latin America
•Asia Pacific
•Europe
•Middle East and Africa

Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global peptide therapeutics market. Some of the major key players explored in the report by Expert Market Research are as follows:
•Pfizer Inc.
•AstraZeneca PLC
•GlaxoSmithKline PLC
•Novartis AG
•Amgen Inc.
•Others
*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Peptide Therapeutics Market Analysis
8.1 Key Industry Highlights
8.2 Global Peptide Therapeutics Historical Market (2017-2021)
8.3 Global Peptide Therapeutics Market Forecast (2022-2027)
8.4 Global Peptide Therapeutics Market by Marketing Type
8.4.1 Generic
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Branded
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.5 Global Peptide Therapeutics Market by Application
8.5.1 Gastrointestinal Disorders
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Neurological Disorders
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Metabolic Disorders
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Cancer
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Cardiovascular
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Others
8.6 Global Peptide Therapeutics Market by Route of Administration
8.6.1 Parenteral
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Oral
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Others
8.7 Global Peptide Therapeutics Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Pfizer Inc.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 AstraZeneca PLC
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 GlaxoSmithKline PLC
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Novartis AG
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Amgen Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
13 Industry Events and Developments

Report Title: Global Peptide Therapeutics Market Report and Forecast 2022-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW